- Home
- MORN vs QGEN Comparison
MORN vs QGEN Comparison
Compare MORN & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MORN
- QGEN
- Stock Information
- Founded
- MORN 1984
- QGEN 1986
- Country
- MORN United States
- QGEN Netherlands
- Employees
- MORN N/A
- QGEN N/A
- Industry
- MORN Investment Managers
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MORN Finance
- QGEN Health Care
- Exchange
- MORN Nasdaq
- QGEN Nasdaq
- Market Cap
- MORN 9.0B
- QGEN 10.7B
- IPO Year
- MORN 2005
- QGEN 1996
- Fundamental
- Price
- MORN $212.29
- QGEN $44.31
- Analyst Decision
- MORN Strong Buy
- QGEN Buy
- Analyst Count
- MORN 3
- QGEN 7
- Target Price
- MORN $333.33
- QGEN $50.68
- AVG Volume (30 Days)
- MORN 407.6K
- QGEN 1.2M
- Earning Date
- MORN 10-29-2025
- QGEN 11-04-2025
- Dividend Yield
- MORN 0.86%
- QGEN 3.38%
- EPS Growth
- MORN 16.18
- QGEN 331.20
- EPS
- MORN 8.80
- QGEN 1.84
- Revenue
- MORN $2,395,400,000.00
- QGEN $2,070,781,000.00
- Revenue This Year
- MORN $8.52
- QGEN $7.37
- Revenue Next Year
- MORN $7.45
- QGEN $5.65
- P/E Ratio
- MORN $24.10
- QGEN $24.28
- Revenue Growth
- MORN 7.76
- QGEN 5.32
- 52 Week Low
- MORN $202.89
- QGEN $37.63
- 52 Week High
- MORN $365.00
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- MORN 40.59
- QGEN 39.97
- Support Level
- MORN $206.68
- QGEN $42.82
- Resistance Level
- MORN $217.20
- QGEN $47.39
- Average True Range (ATR)
- MORN 5.46
- QGEN 1.11
- MACD
- MORN 1.01
- QGEN -0.18
- Stochastic Oscillator
- MORN 51.17
- QGEN 26.33
About MORN Morningstar Inc.
Morningstar Inc is a provider of independent investment research to financial advisers, asset managers, and investors. The company focuses its operations on two core sectors: data and research. It offers data on investments such as mutual funds, stocks, exchange-traded funds, closed-end funds, separate accounts, and variable annuities. Further, the company tracks real-time market data of equity, derivative, currency exchanges, and other investments. In its research operation, Morningstar offers analyst research on passive and active mutual funds, alternative funds, and college saving plans. Morningstar's majority of the revenue is generated in the United States of America.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).